Search Results 651-660 of 14955 for Dental zirconium

1. Nivolumab and Brentuximab Vedotin After Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Classical Hodgkin Lymphoma - Mayo Clinic

   ... oral polio vaccine, and oral typhoid). Refractory to prior brentuximab vedotin (i.e. progression while on treatment). Refractory to prior anti-PD-1/PD-L1 ...

2. Publications - John A. Lucas, Ph.D. - Mayo Clinic

   Mayo's Older African Americans Normative Studies: norms for Boston Naming Test, Controlled Oral Word Association, Category Fluency, Animal Naming, Token ...

3. A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2) - Mayo Clinic

   Able to swallow oral medication. Key Exclusion Criteria: 1. Patients with uveal or mucosal melanoma 2. Prior therapy with an ERK-, MEK-, RAF-, or RAS ...

4. Discovery's Edge: At the World Stem Cell Summit - Mayo Clinic News Network

   “You don't want someone trained as a dentist injecting stem cells into your heart,” she said. Are these treatments within their scope of practice?”.

5. A Study of to Evaluate Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer - Mayo Clinic

   Any condition that impairs the ability to swallow or absorb oral medication (e.g., gastrointestinal tract disease resulting in an inability to take oral ...

6. A Study of the Safety and Effectiveness of Inhaled Mannitol for Adult Patients with Cystic Fibrosis - Mayo Clinic

   Are using non-selective oral beta blockers; Have uncontrolled hypertension -i.e. systolic BP > 190 and / or diastolic BP > 100; Have a condition or in a ...

7. Science Saturday: Seeking a regenerative therapy for chronic dry mouth - Mayo Clinic News Network

   Besides being uncomfortable, chronic dry mouth can lead to difficulties with chewing, tasting, speaking and swallowing. It can also cause tooth decay. Mayo ...

8. Pertuzumab, trastuzumab, and hyaluronidase-zzxf (subcutaneous route) - Mayo Clinic

   Brush and floss your teeth gently. Be careful when using sharp objects, including razors and fingernail clippers. This medicine may cause serious allergic ...

9. A Study Comparing X-396 (Ensartinib) to Crizotinib in Patients with ALK Positive Non-Small Cell Lung Cancer - Mayo Clinic

   Ability to swallow and retain oral medication; Adequate organ system function; Brain metastases allowed if asymptomatic at study baseline; Men willing to use ...

10. Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors - Mayo Clinic

    Patient is unable to swallow or keep down oral medication. Patients at the National Cancer Institute (NCI) site and other selected centers who are willing ...